Clinical Trial Update: Omega-3 Fatty Acids in Adolescent Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating omega-3 fatty acids for adolescent depression has completed, with results posted February 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Adolescent Depression | Phase 2 | Status: COMPLETED | Results posted: 2018-02-15